Support Local Journalism. Join the Cleveland Scene Press Club.

Tuesday, December 7, 2021

DEA Officials Throw Support Behind White House Plan to Make It Easier to Conduct Cannabis Research

Posted By on Tue, Dec 7, 2021 at 5:33 PM

click to enlarge Scientific researchers have voiced concern that current federal rules make it unnecessarily difficult to obtain cannabis and other Schedule I substances. - MICHAEL FISCHER / PIXELS
  • Michael Fischer / Pixels
  • Scientific researchers have voiced concern that current federal rules make it unnecessarily difficult to obtain cannabis and other Schedule I substances.

Federal agencies with oversight of illegal drugs say they support a Biden White House plan that would make it easier for scientists to conduct research on Schedule I drugs such as cannabis and some psychedelics, Marijuana Moment reports.

Officials with the Drug Enforcement Administration and the National Institute on Drug Abuse last week testified at a U.S. House subcommittee hearing in support of easing current research requirements, according to the news service.

“It is critical that the scientific and medical community study Schedule I substances, as some may turn out to have therapeutic value,” DEA Principal Deputy Administrator Louis Milione said, according to Marijuana Moment. “DEA supports the administration’s legislative proposal’s expansion of access to Schedule I research. DEA looks forward to continuing to work with the research community and our interagency partners to facilitate Schedule I research.”

Under the White House's proposal, research rules for Schedule I substances would come into line with those for Schedule II drugs such as methadone or morphine, which face fewer restrictions.

Critics of the current research rules for marijuana and psychedelics say the barriers are so high that they prevent vital study on medical marijuana. That work is also important, they add, as more states legalize cannabis and as consumers turn to hemp derivatives such as delta-8.

Among the White House's planned changes, multiple researchers at a single institution could share a single DEA registration rather than obtain them separately, according to Marijuana Moment. Organizations conducting research at multiple sites also could obtain one registration to cover all of those locations.

Tags: , ,

We welcome readers to submit letters regarding articles and content in Cleveland Scene. Letters should be a minimum of 150 words, refer to content that has appeared on Cleveland Scene, and must include the writer's full name, address, and phone number for verification purposes. No attachments will be considered. Writers of letters selected for publication will be notified via email. Letters may be edited and shortened for space.

Email us at [email protected].

Support Local Journalism.
Join the Cleveland Scene Press Club

Local journalism is information. Information is power. And we believe everyone deserves access to accurate independent coverage of their community and state. Our readers helped us continue this coverage in 2020, and we are so grateful for the support.

Help us keep this coverage going in 2021. Whether it's a one-time acknowledgement of this article or an ongoing membership pledge, your support goes to local-based reporting from our small but mighty team.

Join the Cleveland Scene Press Club for as little as $5 a month.

Read the Digital Print Issue

January 26, 2022

View more issues


Never miss a beat

Sign Up Now

Subscribe now to get the latest news delivered right to your inbox.


© 2022 Cleveland Scene: 737 Bolivar Rd., Suite 4100, Cleveland, OH 44115, (216) 505-8199
Logos and trademarks on this site are property of their respective owners.

Website powered by Foundation